David A. Siegel Guardant Health, Inc. Transaction History
Two Sigma Advisers, LP
- $41.3 Billion
- Q4 2024
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Guardant Health, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 2,315,600 shares of GH stock, worth $99.3 Million. This represents 0.17% of its overall portfolio holdings.
Number of Shares
2,315,600
Previous 1,177,300
96.69%
Holding current value
$99.3 Million
Previous $27 Million
162.05%
% of portfolio
0.17%
Previous 0.07%
Shares
14 transactions
Others Institutions Holding GH
# of Institutions
347Shares Held
120MCall Options Held
793KPut Options Held
1.85M-
Vanguard Group Inc Valley Forge, PA12.1MShares$517 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$482 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT6.42MShares$275 Million8.64% of portfolio
-
Baillie Gifford & CO5.45MShares$234 Million0.13% of portfolio
-
Cadian Capital Management, LP New York, NY5.22MShares$224 Million9.25% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $4.38B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...